These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34393717)
1. N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer's Disease. Domingo G; Benussi L; Saraceno C; Bertuzzi M; Nicsanu R; Longobardi A; Bellini S; Cagnotto A; Salmona M; Binetti G; Ghidoni R Front Neurosci; 2021; 15():708119. PubMed ID: 34393717 [TBL] [Abstract][Full Text] [Related]
2. Synergistic Effect on Neurodegeneration by N-Truncated Aβ Lopez-Noguerola JS; Giessen NME; Ueberück M; Meißner JN; Pelgrim CE; Adams J; Wirths O; Bouter Y; Bayer TA Front Aging Neurosci; 2018; 10():64. PubMed ID: 29568268 [TBL] [Abstract][Full Text] [Related]
3. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153 [TBL] [Abstract][Full Text] [Related]
4. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration. Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689 [TBL] [Abstract][Full Text] [Related]
6. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
8. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology. Tekirian TL J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065 [TBL] [Abstract][Full Text] [Related]
16. An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction. Lin PP; Chen WL; Yuan F; Sheng L; Wu YJ; Zhang WW; Li GQ; Xu HR; Li XN J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():82-91. PubMed ID: 29102244 [TBL] [Abstract][Full Text] [Related]
17. An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. Portelius E; Zetterberg H; Andreasson U; Brinkmalm G; Andreasen N; Wallin A; Westman-Brinkmalm A; Blennow K Neurosci Lett; 2006 Dec; 409(3):215-9. PubMed ID: 17049739 [TBL] [Abstract][Full Text] [Related]
18. Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Vanderstichele H; De Meyer G; Andreasen N; Kostanjevecki V; Wallin A; Olsson A; Blennow K; Vanmechelen E Clin Chem; 2005 Sep; 51(9):1650-60. PubMed ID: 16020497 [TBL] [Abstract][Full Text] [Related]
19. An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer's disease: pyroglutamate amyloid beta. Vukicevic M; Fiorini E; Siegert S; Carpintero R; Rincon-Restrepo M; Lopez-Deber P; Piot N; Ayer M; Rentero I; Babolin C; Bravo-Veyrat S; Giriens V; Morici C; Beuzelin M; Gesbert A; Rivot S; Depretti S; Donati P; Streffer J; Pfeifer A; Kosco-Vilbois MH Brain Commun; 2022; 4(1):fcac022. PubMed ID: 35479516 [TBL] [Abstract][Full Text] [Related]